

We are excited to announce that our portfolio company, Excalipoint Therapeutics, has entered into a clinical trial collaboration with Roche. Under this agreement, Roche will provide atezolizumab (Tecen
… …
We are proud to announce the official establishment of the CO-WINJIANGCHENG Optoelectronics Angel Venture Capital Fund.
… …